
Supporting your cells from scientific concepts to clinical studies with matrices for efficient and reliable cell culture. #StemCells #Organoids
Stockholm
Joined January 2011
- Tweets654
- Following648
- Followers574
- Likes94
BioLamina retweeted
Interested in granular gels, 3D printing, and neuroscience applications? Check out our paper on embedded printing of functional neural constructs inside SHAPE composite materials. biorxiv.org/content/10.1101/…
BioLamina retweeted
We are aware that many academics in the UK are on strike today. A recording of the panel discussion will be available on our website early next week, and we will be continuing the conversation online using the hashtag #ReplacingBMEs for those unable to join us.
There's still time to register for today's final cross-European #3Rs webinar, a panel discussion on the future of basement membrane extracts and their replacements taking place at 11:30–13:30 GMT (12:30–13:30 CET). Register via Zoom 👇
ukri.zoom.us/webinar/registe…
BioLamina retweeted
Inventia Life Science is delighted to be partnering with BioLamina AB to advance cell matrices for complex 3D cell models.
Learn more about the partnership here:
inventialifescience.medium.c…
#3dcellculture #3dcellmodels #partnership #technology
BioLamina retweeted
Laminin isoforms in hydrogels with controlled stiffness and protease degradability that bind growth factors. Defined environments for 3D culture, regeneration and in vitro models @AdvSciNews @theglasgowcemi @OanaDobre8405 @DalbyMatthew @EPSRC @UofGlasgow doi.org/10.1002/adfm.2020102…
BioLamina retweeted
New article: Laminin 521 enhances self-renewal via Stat3 activation and promotes tumor progression in Colorectal Cancer. link.paperbirds.me/RQvzGH #livercancer #oncology
BioLamina retweeted
Replying to @biolamina
@biolamina at #startupday Stockholm is most solid thing I saw on this kind of events
BioLamina retweeted
Today's #mustread ISSCR mbr Malin Parmar: new research potential for hESC therapy to treat #Parkinson's Disease https://xitter.gq/t.co/The5vQD6zV
BioLamina retweeted
Cell Culture and Single Cell Passaging of Human Pluripotent Stem Cells Without the Need for ROCK Inhibitor - cellculturedish.com/2016/05/…
BioLamina retweeted
New Blog: @biolamina's vision is to become the global leader in primary cell culture tools... #BES16 Read more > ow.ly/YnV4C
BioLamina retweeted
Our September focus topic is childhood tumors, read some of recent papers on this published in the Journal ow.ly/REmgF #CCAM.
BioLamina retweeted
On the cover this week: The Top 100 Papers -- Exploring the most-cited research of all time.
BioLamina retweeted
BREAKING NEWS: John O’Keefe @uclnews and @MayBrittMoser @NTNU and Edvard Moser awarded the #nobelprize2014 #medicine
BioLamina retweeted
There are as many as 4,500 clinical trials involving stem cells underway in the U.S. right now nyti.ms/1y8VGCe
BioLamina retweeted
Biological pacemaker smooths rhythm of pig hearts; tech holds promise for humans: ow.ly/zhXkr
BioLamina retweeted
Don't be intimidated by generalized restrictions at #ISSCR2014 sharing is good #openscience
BioLamina retweeted
In Vancouver? This looks great: RT @StemCellNetwork: June 17 at @scienceworldca The Real Deal on Stem Cell Therapies eventbrite.com/e/the-real-de…
BioLamina retweeted
From production to patient: challenges and approaches for delivering cell therapies | StemBook ow.ly/xKG5j
BioLamina retweeted
Who's the best in drug research? 22 companies ranked onforb.es/Sn28SS #pharma #biotech @matthewherper $BMY $CELG $VRTX $GILD $AGN $ROG
BioLamina retweeted
AstraZeneca rejects Pfizer's 'final' £69bn takeover offer - live gu.com/p/3pbed/tw

























